Growth Metrics

Gyre Therapeutics (GYRE) Non-Current Debt: 2009-2014

Historic Non-Current Debt for Gyre Therapeutics (GYRE) over the last 5 years, with Mar 2014 value amounting to $142,000.

  • Gyre Therapeutics' Non-Current Debt fell 84.53% to $142,000 in Q1 2014 from the same period last year, while for Mar 2014 it was $142,000, marking a year-over-year decrease of 84.53%. This contributed to the annual value of $283,000 for FY2013, which is 75.09% down from last year.
  • Gyre Therapeutics' Non-Current Debt amounted to $142,000 in Q1 2014, which was down 49.82% from $283,000 recorded in Q4 2013.
  • Over the past 5 years, Gyre Therapeutics' Non-Current Debt peaked at $2.4 million during Q2 2011, and registered a low of $142,000 during Q1 2014.
  • In the last 3 years, Gyre Therapeutics' Non-Current Debt had a median value of $918,000 in 2013 and averaged $927,444.
  • Per our database at Business Quant, Gyre Therapeutics' Non-Current Debt soared by 100.41% in 2011 and then tumbled by 84.53% in 2014.
  • Over the past 5 years, Gyre Therapeutics' Non-Current Debt (Quarterly) stood at $1.3 million in 2010, then soared by 47.22% to $2.0 million in 2011, then tumbled by 42.80% to $1.1 million in 2012, then tumbled by 75.09% to $283,000 in 2013, then tumbled by 84.53% to $142,000 in 2014.
  • Its Non-Current Debt was $142,000 in Q1 2014, compared to $283,000 in Q4 2013 and $478,000 in Q3 2013.